Columns

Capitol Comments: Reviewing Internal AER Policies

FDA's new guidance documents and recent recalls provide some insight into its perception of a serious adverse event.

Author Image

By: Todd Harrison

Partner, Venable

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters